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Plasmalogens are phospholipids critical for cell function and
signaling that contain a vinyl ether linkage at the sn-1 position
and are highly enriched in arachidonic acid (AA) at the sn-2
position.However, the enzyme(s) responsible for the cleavage of
the vinyl ether linkage in plasmalogens has remained elusive.
Herein, we report that cytochrome c, in the presence of either
cardiolipin (CL), O2 andH2O2, or oxidized CL andO2, catalyzes
the oxidation of the plasmalogen vinyl ether linkage, promoting
its hydrolytic cleavage and resultant production of 2-AA-lyso-
lipids and highly reactive -hydroxy fatty aldehydes. Using
stable isotope labeling in synergy with strategic chemical
derivatizations and high-mass-accuracy MS, we deduced the
chemicalmechanismunderlying this long sought-after reaction.
Specifically, labeling with either 18O2 or H218O, but not with
H218O2, resulted in M 2 isotopologues of the -hydroxyalde-
hyde,whereas reactionswith both 18O2 andH218O identified the
M 4 isotopologue. Furthermore, incorporation of 18O from
18O2 was predominantly located at the -carbon. In contrast,
reactions withH218O yielded 18O linked to the aldehyde carbon.
Importantly, no significant labeling of 2-AA-lysolipids with
18O2, H218O, or H218O2 was present. Intriguingly, phosphatidy-
linositol phosphates (PIP2 and PIP3) effectively substituted for
cardiolipin. Moreover, cytochrome c released from myocardial
mitochondria subjected to oxidative stress cleaved plasmenyl-
choline in membrane bilayers, and this was blocked with a spe-
cific mAb against cytochrome c. Collectively, these results iden-
tify the first plasmalogenase in biology, reveal the production of
previously unanticipated signaling lipids by cytochrome c, and
present new perspectives on cellular signaling during oxidative
stress.
Plasmalogens are phospholipids that contain a cis-vinyl ether
linkage at the sn-1 position of the glycerol backbone and are
essential for physiologic cellular function (1, 2). Typically, plas-
malogens are highly enriched in polyunsaturated fatty acids,
especially arachidonic acid, at the sn-2 position (3, 4). The
unique properties of plasmalogens influence membrane struc-
ture andmolecular dynamics,modulate the function of integral
membrane proteins, and contribute to the phospholipase-me-
diated release of signaling fatty acids during cellular stimulation
(5–9). Deficiencies in plasmalogen content have identified
important roles for these specialized phospholipids inmodulat-
ing signal transduction (10), cell proliferation (11), cholesterol
trafficking (12), and sensitivity to oxidative stress (13, 14).
Moreover, human genetic mutations leading to deficiencies
in plasmalogen biosynthesis (e.g. PEX7 and alkylglycerone
phosphate synthase (AGAPS)) unambiguously demonstrate
that the absence of plasmalogens results in severe human dis-
ease (15–17). However, the cellular mechanisms mediating
these phenomena, the enzymes that catalyze the cleavage of
the sn-1 vinyl ether in plasmalogens (plasmalogenases), and
mechanistic identification of the biologic functions of plas-
malogens have remained largely enigmatic.
Mammalian myocardium contains substantial amounts of
plasmalogens (25% of total myocardial phospholipids and
60% of sarcolemmal phospholipids) that are highly enriched
in arachidonic acid (AA)3 at the sn-2 position. Furthermore,
plasmalogen molecular species contain the majority of AA in
many human cell types. Accordingly, delineation of the molec-
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ular pathways mediating the cellular metabolism of plasmalo-
gens is of paramount importance to understand their roles in
cellular functions. However, despite intense efforts, an enzyme
catalyzing the cleavage of the vinyl ether linkage in plasmenyl-
choline or plasmenylethanolamine, plasmalogenase, has eluded
identification for nearly a century.
Oxidative stress is a major participant in mediating many of
the pathologic processes present in diabetic cardiomyopathy,
myocardial infarction/reperfusion, and the progression of heart
failure (18–20). Mitochondria occupy over 30% of cardiac vol-
ume (21) and are the primary source of reactive oxygen species
generated during myocardial ischemia/reperfusion injury (22–
25). Furthermore, during ischemia/reperfusion, rapid changes
inmitochondrialmembrane potential and permeabilization (or
rupture) of the outer membrane occur, leading to the release of
cytochrome c (cyt c) (26–28). The release of cyt c from the
intermembrane space allows its access to multiple signaling
proteins, scaffolding complexes, and distal intracellular mem-
brane compartments (29–31).
Under physiologic conditions, cyt c is bound to the inner
mitochondrial membrane where it transfers electrons from
complex III to complex IV. As an electron transfer protein, cyt
c possesses a high redox potential (260 mV) and a compact
tertiary structure containing a covalently bound heme iron.
Upon interaction with negatively charged phospholipids (32),
especially cardiolipin (33), cyt c undergoes a conformational
alteration with subsequent displacement of the axial Met-80
that is accompanied by a dramatic decrease in its redox poten-
tial to400mV. This prevents cyt c from serving as an electron
transporter and allows access of hydrogen peroxide (produced
by mitochondrial superoxide dismutase) to the heme moiety,
conferring peroxidase activity to the conformationally altered
cyt c. Previous work has shown that cardiolipin (CL)-bound
cytochrome c can oxidize the polyunsaturated linoleoyl acyl
chains in cardiolipin (34, 35), which can subsequently be
released by calcium-independent phospholipase A2 (36).
Based upon the known chemical sensitivity of the plasmalo-
gen vinyl ether linkage to oxidation (37), we hypothesized that
the peroxidase activity of cardiolipin-activated cytochrome c
could oxidatively metabolize the vinyl ether bond in plasmalo-
gens, leading to an intermediate that was susceptible to hydro-
lytic cleavage. Herein, we report that CL-activated cyt c cata-
lyzes the oxidatively enabled hydrolytic cleavage of the vinyl
ether linkage of plasmenylcholine and plasmenylethanolamine
in the presence of H2O2 or alternatively by oxidized CL. The
products of the reaction, 2-acyl-lysophospholipids and -hy-
droxy fatty aldehydes, were identified either directly by high-
resolution accurate-mass (HRAM)MSand fragmentation anal-
yses or through synergistic chemical derivatization strategies
and HRAM MS of derivatized precursor ions and their frag-
mentation-induced product ions. Importantly, we demonstrate
that oxidized CL can activate the plasmalogenase activity of cyt
c even in the absence of H2O2. To the best of our knowledge,
this is the first identification of a protein that can catalyze the
cleavage of the vinyl ether linkage of plasmalogens, thereby
identifying multiple previously unknown cellular lipid meta-
bolic pathways that participate in cellular metabolism, signal-
ing, and cell fate decisions.
Results
Conformationally altered cytochrome c is a potent
plasmalogenase
Because CL-activated cytochrome c is a potent lipid peroxi-
dase in the presence of H2O2 (38), based upon energetic and
molecular orbital considerations, we hypothesized that cyt c
could catalyze the cleavage of the vinyl ether linkage present in
plasmalogens. To test this hypothesis, we purified equine heart
cytochrome c from Sigma by Mono S FPLC using an NaCl gra-
dient. The purified cyt c migrated as a single band by SDS-
PAGE andwas99% pure by silver staining (Fig. S1). The puri-
fied cyt c was incubated with small unilamellar vesicles (SUVs)
comprising 1-O-1-(Z)-octadecenyl-2-arachidonoyl-sn-glycero-
3-phosphocholine (plasmenyl-SAPC) as host containing 10
mol % bovine heart CL (predominantly tetra-18:2 CL) as guest
in the absence or presence of H2O2 for 10 min at 37 °C. We
focused on CL because it is markedly enriched inmitochondria
and has been previously demonstrated to bind to cyt c inducing
a conformational change that activates its cryptic peroxidase
activity (34, 39–42). In initial experiments, reactions were
monitored for the production of LPC by shotgun lipidomics.
Minimal plasmalogenase activity was observed in the absence
or presence of H2O2 alone (Fig. 1A). Similarly, incubations with
cyt c alone also resulted in barely detectable cleavage of the
plasmenylcholine vinyl ether linkage (minor peak atm/z 566.4
by ESI-MS/MS) (Fig. 1A). Addition of H2O2 dramatically acti-
vated cyt c plasmalogenase activity, resulting in the robust gen-
eration of 2-AA-LPC (Fig. 1A). In contrast, similar experiments
with diacyl SAPC-CL SUVs did not result in appreciable pro-
duction of either 1-stearoyl-LPC or 2-AA-LPC in the presence
of cyt c and H2O2 (data not shown). Incubation of SUVs com-
prising 1-O-1-(Z)-octadecenyl-2-arachidonoyl-sn-glycero-3-
phosphoethanolamine (plasmenyl-SAPE) (45 mol %) contain-
ing 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)
(45 mol %) and 10 mol % bovine heart CL in the presence of cyt
c resulted in the production of 2-AA-LPE, which was markedly
increased in the presence of H2O2 (Fig. 1B).
Substantiation of cytochrome c as a plasmalogenase
Further characterization of the plasmalogenase activity of
cytochrome c revealed that production of 2-AA-LPC fromplas-
menyl-SAPC depended upon the amount of purified cyto-
chrome c (Fig. 2A) with amaximum apparent turnover number
of 6 at low concentrations of cyt c (1 M). The reaction was
also dependent on the concentration of H2O2 (Fig. S2A) as well
as on themol% cardiolipin present in the host plasmenyl-SAPC
vesicles (Fig. S2B). Kinetic analysis of reaction products at a
fixed concentration of cytochrome c (5 M) in the presence
of H2O2 (200 M) demonstrated a linear increase in 2-AA-
LPC and 2-AA-LPE production utilizing plasmenyl-SAPC/1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine or plas-
menyl-SAPE/POPC SUVs, respectively, each containing 10
mol % CL as guest to mimic physiologic conditions (Fig.
S2C). The initial catalytic rates of vinyl ether cleavage were
50 nmol of 2-AA-LPC/minmg of cyt c and 60 nmol of
2-AA-LPE/minmg of cyt c.
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We next examined the susceptibility of the plasmalogenase
reaction to various inhibitors. Importantly, a cyt c–specific
mAb resulted in the nearly complete inhibition ofH2O2-depen-
dent cyt c plasmalogenase activity (Fig. 2B). Moreover, cyanide
and azide inhibited the plasmalogenase activity as has been
shown for inhibition of the peroxidase activity of cyt c (43, 44)
(Fig. 2B). Although the singlet oxygen scavengers lycopene and
-carotene did not appreciably affect cyt c–mediated plasmalo-
genase activity, the lipid hydroperoxyl scavenger -tocopherol
markedly inhibited the measured plasmalogenase activity (Fig.
2C). Interestingly, bifonazole, a cytochrome P450 inhibitor that
inhibits the peroxidase activity of cyt c (45), potently inhibited
cyt c–mediated plasmalogenase activity (Fig. 2C). To rule out
the possible contribution of free heme or free iron to the
observed plasmalogenase activity, hemin or ferric chloride was
substituted for cyt c in the presence of hydrogen peroxide. Incu-
bations with these reagents did not result in appreciable plas-
malogenase activity (Fig. S3A). Additional experiments with
catalase and nitric-oxide synthase revealed that these heme
proteins exhibited10% and no plasmalogenase activity com-
pared with cyt c, respectively (Fig. S3B), suggesting that cyto-
chrome c is relatively specific for cleavage of the plasmalogen
vinyl ether linkage. We specifically point out that these results
do not preclude the possibility that other heme proteins may
also be capable of cleaving the plasmalogen vinyl ether bond.
Collectively, these results firmly identify cytochrome c as an
enzymic mediator of the cleavage of the plasmalogen vinyl
ether linkage.
Identification of the regiospecificity of the lysolipid reaction
products from plasmenylcholine and plasmenylethanolamine
To establish the regiospecificity of the arachidonoyl moiety
in the lysolipids produced by cyt c–catalyzed plasmalogenase
activity, full-mass MS2 analyses of the lysolipid products and
authentic synthetic 2-AA-LPC and 2-AA-LPE standards were
























Figure 1. Mass spectrometric analyses of the plasmalogenase reaction products. A, plasmenyl-SAPC/CL (50 nmol/5 nmol) SUVs in 200 l were
incubated in the presence of cytochrome c (10 M) and/or H2O2 (250 M) or in the absence of both (BKG) for 10 min at 37 °C. Following addition of 17:0
LPC (m/z 532.4) as internal standard (I.S.), resultant lipids were extracted into chloroform (Bligh-Dyer extraction) and directly analyzed by ESI-MS/MS in
the positive-ion mode through tandem mass spectrometric analysis through neutral loss scanning at m/z 59 for sodiated LPC species as described
previously (71). B, plasmenyl-SAPE (45 mol %) in POPC (45 mol %) SUVs containing 10 mol % CL were incubated in the presence of cyt c and/or H2O2 or
in the absence of H2O2 and cyt c (BKG) at 37 °C for 10min. Following addition of internal standard (14:0 LPE;m/z 426.5), reaction products were extracted
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Figure 2. Dependence of plasmalogenase activity on cytochrome c and susceptibility of the cyt cplasmalogenase reaction to various inhibitors.
A, cytochrome c at the indicated concentrations was incubated with plasmenyl-SAPC (250 M)/CL (25 M) SUVs in the presence of H2O2 (250 M) in 10
mM potassium phosphate, pH 7.0, containing 0.25 mM DTPA (200-l reaction volume) for 10 min at 37 °C. Error bars represent S.E. of at least three
separate experiments. B, inhibition of cytochrome c plasmalogenase activity with either an anti-cytochrome c mAb (Ab), NaN3 (2 mM), or NaCN (2 mM).
The mAb directed against cyt c was preincubated with cyt c prior to the assay for plasmalogenase activity. C, effect of singlet oxygen scavengers
-carotene (-Car) and lycopene (Lyc), the lipid peroxyl radical scavenger-tocopherol (-Toc), or the cytochrome P450 inhibitor bifonazole (BFZ) on the
plasmalogenase activity of cytochrome c. Following addition of internal standards (17:0 LPC and 14:1 PC), reaction products were extracted and
analyzed as described under “Experimental procedures.”
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(shown as mirror plots) were obtained between the lysolipid
reaction products and corresponding authentic 2-AA-LPC and
2-AA-LPE standards (Fig. 3,A andD). For 2-AA-LPC, the pres-
ence of a high abundance product ion atm/z 147.1 (i.e. sodiated
ethylene phosphane) demonstrated the regiospecificity of the
arachidonate group at the sn-2 position as described previously
(46). We also performed high-mass-accuracy MS1 and MS2
analyses of the 2-AA-LPC and 2-AA-LPE assay products by
HRAMMS. Each of the measured masses of the molecular ion






























































































Reaction Product Reaction Product


















Figure 3. Mass spectrometric structural confirmation of 2-AA-LPC and 2-AA-LPE generated from plasmenyl-SAPC and plasmenyl-SAPE by the plas-
malogenase activity of cytochrome c in the presence of H2O2. A, full-mass MS
2 analysis of both plasmalogenase assay product and synthetic 2-AA-LPC at
m/z 566.2 was performed on a triple-quadrupole mass spectrometer. An excellent match of the two MS2 spectra are displayed as a mirror plot, including the
presence of high-abundance product ion atm/z 147.1 (i.e. sodiated ethylene phosphate), which indicates the regiospecific acylation at the sn-2 position of LPC
species (71).B andC, HRAMMS1 andMS2mass spectrometric analysis of the assayproduct atm/z566.3223 fromAwas alsoperformedonanLTQ-Orbitrapmass
spectrometer. The measured m/z values of the product ions (at m/z 507.2491 and 383.2559) resulting from loss of trimethylamine and phosphocholine,
respectively, confirm the identity of the phosphocholine headgroup in LPCwith eachwithin	2 ppmof theoretical values. In panel B, the peak corresponding
tom/z532.3380 is the17:0 LPC internal standard.D,MS2 analysis of both theplasmalogenase assayproduct and synthetic 2-AA-LPE atm/z524 (sodiumadduct)
was performed on a triple-quadrupole mass spectrometer. The MS2 spectra demonstrate the presence of diagnostic fragment ions (prominent m/z 164
(sodiated phosphoethanolamine) andm/z 383 (sodiated arachidonoyl glycerol) peaks) indicative of 2-AA-LPE (46). E and F, HRAMMS1 andMS2mass spectro-
metric analysis of the assay product atm/z 524.2752 fromDwas also performedon an LTQ-Orbitrapmass spectrometer showing fragment ions corresponding
to the accurate mass	2 ppm of the aforementioned product ions. In panel E, the peak corresponding tom/z 448.2436 is the 14:0 LPE internal standard.
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ppm of their calculated theoretical masses (Fig. 3, B, C, E,
and F).
Identification of the oxidized sn-1 chain aliphatic constituents
To determine the reaction products resulting from oxidative
cleavage of the vinyl ether bond, we utilized synergistic de-
rivatization strategies to avoid the rapid postsource decay of
the anticipated aldehyde reaction products. After incubation
of cyt cwith plasmenyl-SAPC/CL (90:10) SUVs in the presence of
H2O2, the resultant aldehydes were derivatized withO-benzyl-
hydroxylamine (BOA). High-mass-accuracy MS spectra of
aldehyde BOA derivatives demonstrated an intense molecular
ion atm/z 390.3365 (Fig. 4A), indicative of the anticipated prod-
uct of the C18:0 -hydroxyaldehyde BOA adduct. Fragmenta-
tion of the molecular ion at m/z 390.3365 resulted in the
appearance of a predominant peak at 372.3242 resulting from
loss of H2O (Fig. 4B). Similar BOA derivative ions were
obtained when plasmenyl-SAPE/POPC/CL vesicles were used
as substrate (Fig. 4, C and D). To further confirm the presence
of the hydroxyl group in the resultant aldehyde product, dim-
ethylglycine (DMG)was used to derivatize the hydroxyl groups.
An intensemolecular ion atm/z 370.3328 corresponding to the
mass of the C18:0 -hydroxyaldehyde DMG derivative was
routinely observed (Fig. 4E). Similar results were obtained
when plasmenyl-SAPE was used as substrate (Fig. 4F). Col-
lectively, these results demonstrate that cytochrome c–
mediated oxidative cleavage of the vinyl ether bond of plas-
malogens generates lysophospholipids and -hydroxy fatty
aldehydes as products.
Activation of cyt c–mediated plasmalogenase activity by
oxidized CL alone or by phosphatidylinositol phosphates in
the presence of H2O2
Because cardiolipin is likely oxidized by cyt c during the plas-
malogenase reaction, we examined whether CL preoxidized
with cyt c in the presence of H2O2 could activate the plasmalo-
genase activity of cyt c in the absence of exogenous H2O2 in the
reaction mixture. First, cardiolipin was oxidized by cyt c in the
presence of hydrogen peroxide (35). Second, oxidized CL
molecular species were purified by HPLC and analyzed by
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Figure 4. Mass spectrometric identification of-hydroxyaldehyde products in cytochrome c–catalyzed plasmalogenase reactions. Plasmenyl-SAPC/
POPC (A, B, and E) or plasmenyl-SAPE/POPC (C, D, and F) vesicles containing 10 mol % bovine heart CL (predominantly tetra-18:2 CL) were incubated at 37 °C
for 30min in thepresenceof cyt c (20M) andH2O2 (200M). Aliphatic-hydroxyaldehydeswereextracted into cyclohexane/diethyl ether (4:1) andderivatized
with either BOA or DMG. Derivatives were analyzed by HRAMMS. MS2 product ion scans of the C18:0 -hydroxyaldehyde derivatized with BOA (m/z 390.336)
in B and D show a product ion peak atm/z 372.325 upon neutral loss of H2O.
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HRAMMS. Spectra revealed the presence of multiple oxidized
molecular species with an approximate 1:1 mixture of hy-
droperoxides and hydroxides, similar to results described pre-
viously (35). Next, we incorporated the HPLC-purified cyt
c–oxidized CL (10 mol %) as guests into plasmenyl-SAPC SUV
hosts by sonication and then measured the plasmalogenase
activity of cyt c using these SUVs as substrate containing oxi-
dized CL in the absence of additional H2O2. Remarkably, inclu-
sion of cyt c–oxidized CL fully reconstituted the plasmaloge-
nase activity even in the absence of exogenous H2O2 (Fig. 5A,
upper panel). Additionally, cyt c–catalyzed plasmalogenase
activity could be further increased by the addition of H2O2 (Fig.
5A, upper panel). Previous reports have indicated that cyto-
chrome c binds less tightly to oxidized CL compared with non-
oxidized CL. We performed vesicle binding experiments with
plasmenyl-SAPC large unilamellar vesicles (LUVs) containing
either 1) no CL, 2) 10 mol % nonoxidized CL, or 3) 10 mol %
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does not appreciably bind to vesicles in the absence of cardio-
lipin it readily binds to plasmenyl-SAPC LUVs containing
either nonoxidized or oxidized CL (Fig. 5A, lower panel). These
results are consistent with the CL-dependent activation of cyt c
plasmalogenase activity (Fig. S2B).
Next, we hypothesized that other negatively charged phos-
pholipids such as PI(4,5)P2 and PI(3,4,5)P3 (which are enriched
in the plasma membrane) could also act to transform cyt c into
a potent plasmalogenase after its release from the mitochon-
drial intermembrane space. Accordingly, we examined the abil-
ity of 5 mol % PI(4,5)P2 or PI(3,4,5)P3 as guests in host plasme-
nyl-SAPC SUVs in the presence of H2O2 to activate cyt c
plasmalogenase activity. The results demonstrated robust acti-
vation of plasmalogenase activity with phosphatidylinositol
phosphates similar to that observed with CL, suggesting that
released cyt c activated by association with negatively charged
lipids has multiple membrane targets after its release from the
mitochondria (Fig. 5B).
Mitochondrial cytochrome cmediated plasmalogenase
activity
Next, we examined whether cyt c released from rabbit heart
mitochondria by outer membrane permeabilization could
cleave the vinyl ether linkage of plasmenyl-SAPC in exogenous
SUVs containing CL. Incubation of rabbit heart mitochondria
in the presence of KCl and calcium phosphate resulted in swell-
ing of the mitochondria and the robust release of cyt c as dem-
onstrated byWestern blot analysis of the mitochondrial super-
natant with a specific anti-cyt cmAb (Fig. 5C). After removal of
the mitochondria by centrifugation, the resultant supernatant
was incubated with plasmenylcholine vesicles containing 10
mol % oxidized CL in the absence or presence of a specific mAb
against cyt c. Similar to incubations with purified cyt c, addition
of the anti-cyt c mAb to stressed rabbit heart mitochondrial
supernatants resulted in marked inhibition of plasmalogenase
activity, indicating that cyt c was responsible for the observed
activity (Fig. 5C).
Human heart mitochondria contain abundant plasmalogen
molecular species
Mammalian myocardium is known to be enriched in plas-
malogenmolecular species (7). Previously, subcellular fraction-
ation and mass spectrometric analysis of phospholipids from
canine myocardium revealed substantial enrichment of plas-
malogens in sarcolemmal and sarcoplasmic reticular mem-
branes (3, 4). To determinewhethermitochondrialmembranes
contained plasmalogens representing a proximal target for
cytochrome c plasmalogenase activity, we measured choline
and ethanolamine plasmalogens in human heart mitochondria
by shotgun lipidomics. The results demonstrated that human
heart mitochondria contain an abundance of both ethanol-
amine and choline plasmalogens enriched in AA (Fig. 5D).
These results strongly suggest that cytochrome c localized to
human heart mitochondria generates plasmalogen-derived
lipid second messengers during oxidative stress.
Metabolic labeling of cytochrome c plasmalogenase reaction
products in the presence of 18O2, H2
18O2, and/or H2
18O
To gain insight into the chemical mechanisms through
which cyt c catalyzes the cleavage of the vinyl ether linkage in
the plasmalogenase reaction, we incubated cyt c with plasme-
nylcholine vesicles containing 10 mol % CL in the presence of
either 18O2, H218O, H218O2, or 18O2 and H218O together. The
reaction products were derivatized with either BOA (for
derivatization of aldehydes) (47) or DMG (for derivatization of
hydroxyl groups). These reactions were each selected for the
high ionization efficiency of their derivatives and their ability to
substantiate the identities of the proposed reaction products
(48). Control incubations of cyt c with 10 mol % oxidized
CL/plasmenyl-SAPC vesicles in the presence of supplemental
16O2 and H216O resulted in the appearance of a BOA adduct at
m/z 390.3365 (Fig. 6A), which upon fragmentation yielded a
diagnostic product ion at m/z 372.3242 consistent with loss of
H216O (Fig. 7A). Substitution of 18O2 for 16O2 resulted in the
formation of a BOA adduct containing one 18O atom (m/z 

392.3387) (Fig. 6B), which upon fragmentation yielded a prod-
uct ion atm/z 372.3241 (loss of H218O (m/z
 20.0146)) (Fig.
7B). Because derivatization of aldehydes with BOA results in
loss of the aldehyde oxygen during formation of the oxime (47),
one of the oxygen atoms in molecular oxygenmust be incorpo-
rated into the aliphatic chain of the aldehyde product, likely as
an -hydroxyl group that readily loses water upon fragmenta-
tion. In contrast, reactions performed inH218Odid not result in
Figure 5. Substitution of oxidized CL reconstitutes cytochrome c–mediated plasmalogenase activity in the absence of H2O2, binding of cyt c to
plasmenyl-SAPC LUVs, kinetics of plasmalogenase activity in the presence of PI(4,5)P2 or PI(3,4,5)P3, hydrolysis of plasmenylcholine by cytochrome
c released from rabbit heart mitochondria, and abundance of plasmalogens in human heart mitochondria. A, upper panel, plasmenyl-SAPC vesicles
containing either 10mol%bovine heart CL (predominantly tetra-18:2 CL) or bovine heart CL previously oxidizedwith cyt c andH2O2 (35) were incubatedwith
cyt c (10M) in the presence or absence of H2O2 (200M) for 10min at 37 °C. Reaction products extracted into chloroform (Bligh-Dyer) in the presence of 17:0
LPC internal standard were analyzed by tandem MS in the positive-ion mode. Lower panel, binding of cyt c to plasmenylcholine large unilamellar vesicles.
Purified cyt c (2.5 M final concentration) was mixed with plasmenyl-SAPC LUVs (0.8 m) in the absence or presence of 10 mol % CL or 10 mol % oxidized CL
(CLox) at 23 °C in 10 mM potassium phosphate, pH 7.0, containing 0.25 mM DTPA prior to ultracentrifugation (100,000 g for 60 min) at 15 °C. Pellet (P) and
supernatant (S) fractionswere resolved by SDS-PAGE and visualized by ECLWestern blot analysis as described under “Experimental procedures.” B, plasmenyl-
SAPC vesicles containing either 10mol%PI(4,5)P2 (PIP2) or PI(3,4,5)P3 (PIP3) were incubatedwith cyt c (10M) in thepresence ofH2O2 (200M) for the indicated
times. After addition of 17:0 LPC internal standard, resultant 2-AA-LPC was quantified by LC-MS. Error bars in A and B represent S.E. for at least three separate
experiments.C, mitochondriawere isolated from rabbitmyocardiumand incubated in sucrose-mannitol buffer in the absence (control) or presence of KCl and
calciumphosphate to release cyt c. Followingpelleting of swollenmitochondria by centrifugation, the resultant supernatantswere incubatedwith plasmenyl-
SAPC vesicles containing 10mol%oxidized CL for 20min at 37 °C under the indicated conditions. Following extraction into chloroform (Bligh-Dyer), 2-AA-LPC
wasquantifiedby tandemmass spectrometryusing17:0 LPCas an internal standard.Datapresentedare fromtwoseparateexperimentsperformed in triplicate
(x¯ 	 S.E., n 
 6; *, p  0.02; **, p  0.05). The content of cyt c in the supernatant fractions was determined by ECL Western blot analysis. CMS, control
mitochondrial supernatant; SMS, swollen mitochondrial supernatant; mAb, anti-cyt c mAb. D, PE (Fmoc-derivatized, upper panel) and PC (lower panel) plas-
malogens present in human heart mitochondria. The presence of plasmenylcholine and plasmenylethanolamine molecular species (beige shaded regions)
were confirmedby their sensitivity to acidhydrolysis.Major plasmenylethanolaminemolecular species containing arachidonic acid are as follows (P represents
plasmenyl): P16:0–20:4 PE (m/z 944.8), P18:1–20:4 PE (m/z 970.8), and P18:0–20:4 PE (m/z 972.8). Major plasmenylcholine molecular species containing
arachidonic acid are as follows: P16:0–20:4 PC (m/z 766.5), P18:1–20:4 PC (m/z 792.5), and P18:0–20:4 PC (m/z 794.5). I.S., internal standard.
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a similar mass shift (M  2) in the BOA adduct (Figs. 6C and
7C). As expected, incubations in the presence of 18O2 and
H218O yielded an [18O]BOA adduct (m/z 
 392.3387), which
upon fragmentation resulted in loss ofH218O (Figs. 6D and 7D).
Parallel derivatization of the 16O2  H216O reaction products
with DMG resulted in a predominant parent ion at m/z
370.3326 (Fig. 8A) as observed in Fig. 4E. Fragmentation of this
ion yielded product ions corresponding to protonated DMG
containing 16O (m/z 104.0709) and a deformylated DMG frag-
ment ion (m/z 58.0655) (Fig. 9A). For incubations containing
either 18O2  H216O or 16O2  H218O, a parent ion at m/z
372.3367 was observed, indicating incorporation of one 18O
atom into the DMG derivative (Fig. 8, B and C). Fragmentation
of this ion (m/z
 372.3367) yielded ions at bothm/z 104.0709
andm/z 106.0749 with the latter ion indicating the presence of
18O in protonated DMG that was originally present in the
hydroxyl group of the -hydroxyaldehyde (Fig. 9, B and C).
Importantly, incubations with both 18O2 andH218O resulted in
the expected M 4 peak at m/z 374.3399, which was not
observed from incubations with 18O2  H216O or 16O2 
H218O, indicating incorporation of two 18O atoms from 18O2
and H218O into the DMG adduct (Fig. 8D). Fragmentation of
this molecular ion generated a predominant protonated DMG
product ion atm/z 106.0750 (Fig. 9D). Remarkably, incubations
with hydrogen [18O]peroxide did not result in significant
(5%) incorporation of 18O into the DMG derivative of the
C18:0 -hydroxyaldehyde (Fig. S4). We specifically point out
that exchange of the aldo, keto, and gem-diol forms of the
-hydroxyaldehyde in water likely contributes to the ob-
served distribution of the 18O label present in the proto-
nated DMG product ion. Mechanistically, these studies sug-
gest that cyt c likely abstracts an electron from the stabilized
resonance form of the vinyl ether bond to form a carbon-
based radical that reacts with molecular oxygen to form a
peroxy or epoxide intermediate (Fig. 10). Next, the positive
charge on the vinyl ether oxygen is relieved by addition of
H2O to form a hemiacetal, which then spontaneously rear-
ranges at neutral pH to yield the resultant -hydroxyalde-
hyde and 2-acyl-lysolipid products.
Discussion
Despite nearly a century of investigation, the identity of the
enzyme(s) responsible for the cleavage of the vinyl ether linkage
in plasmenylcholine and plasmenylethanolamine has remained



























































































































18O2 + H216O 
16O2 + H218O 
MS1
MS1MS1
Figure6. Incorporationof18Ofrom18O2 intotheBOA-derivatized-hydroxyaldehydeproductof theplasmalogenasereactionofcytochromec.Plasmenyl-
SAPC vesicles containing 10mol % oxidized CLwere incubatedwith cyt c in the presence of 16O2 and H2
16O (A), 18O2 and H2
16O (B), 16O2 and H2
18O (C), or 18O2 and
H2
18O (D) for 30min at 37 °C. Reaction products were extracted into cyclohexane/diethyl ether (4:1), derivatized with BOA, and analyzed byMS as described under
“Experimental procedures.” Peaks of BOA-derivatized-hydroxyaldehydes labeledwith 16O or 18O are shown atm/z 390.3365 or 392.3405, respectively.
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an enigma. Herein, we report the first molecular identification
of a plasmalogenase in biology. The reaction mechanism is
unique in that it utilizes the initial oxidation of the vinyl ether
linkage by conformationally altered cyt c activating its cryptic
peroxidase activity. Stable isotope experiments demonstrated
that this leads to the addition of molecular oxygen to the -car-
bon followed by the addition of water, yielding a hemiacetal
intermediate that spontaneously rearranges at neutral pH to
generate a 2-acyl-lysolipid and an -hydroxyaldehyde (Fig. 10).
Furthermore, the present study demonstrates that the vinyl
ether linkage in plasmenylcholine and plasmenylethanolamine
can be readily cleaved by cyt c in the presence of negative-
ly charged phospholipids (e.g. tetra-18:2 CL, PI(4,5)P2, or



















































































































Figure7.High-mass-accuracyMS2analysis of stable isotope–labeledBOA–-hydroxyaldehydederivatives.Plasmenyl-SAPCvesicles containing10mol
% oxidized CLwere incubatedwith cyt c in the presence of 16O2 andH2
16O (A), 18O2 andH2
16O (B), 16O2 andH2
18O (C), or 18O2 andH2
18O (D) for 30min at 37 °C.
Reaction products were extracted into cyclohexane/diethyl ether (4:1), derivatized with BOA, and analyzed by MS as described under “Experimental proce-
dures.” Themass of isotopic water (i.e.m/z
 20.0146) lost upon fragmentation of the ion atm/z 392.3387 (indicated between the red arrows) is indicative of
the 18O isotopic label present in the -hydroxyl group of the C18:0 -hydroxyaldehyde BOA derivative.
































16O2 + H216O 
DMG-C18:0
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18O2 + H216O 





Figure 8. Incorporation of 18O from 18O2 and H2
18O into the DMG-derivatized -hydroxyaldehyde product of the plasmalogenase reaction of cyto-
chrome c. Plasmenyl-SAPC vesicles containing 10mol % oxidized CLwere incubatedwith cyt c in the presence of 16O2 and H2
16O (A), 18O2 and H2
16O (B), 16O2
and H2
18O (C), or 18O2 and H2
18O (D) for 30 min at 37 °C. Reaction products were extracted into cyclohexane/diethyl ether (4:1), derivatized with DMG, and
analyzed byMS as described under “Experimental procedures.” Peaks of DMG-derivatized C18:0 -hydroxyaldehydes labeled with 16O, 18O, or two 18O atoms
are shown atm/z 370.3326, 372.3370, or 374.3404, respectively.
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Figure 10. Proposed catalytic mechanism of the cytochrome c plasmalogenase reaction. The plasmalogen vinyl ether linkage exists as a resonance
structure in which the oxygen can acquire a positive charge upon migration of an electron to the -carbon. Cytochrome c extracts an electron from the
-carbon to form a carbon-based radical, which then readily reacts with molecular oxygen to form a peroxyl radical intermediate. After abstraction of a
hydrogen radical (from any molecule (AH) that is a H donor) to form the hydroperoxide, this intermediate may then undergo either direct hydroperoxide
cleavage to form a hydroxy intermediate or epoxidation to form an epoxide intermediate. Relief of the positive charge on the vinyl ether oxygen by water in
both cases results in the formation of a common diol intermediate, which then undergoes a hemiacetal rearrangement to yield lysolipid and -hydroxyalde-
hyde products. R
 lysolipid backbone.






















































































































































Figure 9. High-mass-accuracy MS2 analysis of stable isotope–labeled DMG–-hydroxyaldehyde derivatives. Plasmenyl-SAPC vesicles containing 10
mol % oxidized CL were incubated with cyt c in the presence of 16O2 and H2
16O (A), 18O2 and H2
16O (B), 16O2 and H2
18O (C), or 18O2 and H2
18O (D) for 30min at
37 °C. Reaction products were extracted into cyclohexane/diethyl ether (4:1), derivatized with DMG, and analyzed by MS as described under “Experimental
procedures.”
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Previous studies have demonstrated the susceptibility of neg-
atively charged lipids (e.g. CL and phosphatidylserine) to bind
and induce conformational alterations that transform cyt c
from an electron carrier to a potent peroxidase that can extract
the bisallylic protons in CL (34, 38, 49). The resultant allylic
radicals readily add molecular oxygen, resulting in the genera-
tion of CL hydroperoxides that can then be reduced to hydrox-
ides (34). In contrast, incubations with zwitterionic diacyl PC
and PE containing polyunsaturated fatty acyl chains were not
effective in inducing cyt c–mediated oxidation in our hands and
in agreement with previous studies (50). Our results demon-
strate that cyt c is a highly active plasmalogenase after confor-
mational alterations by negatively charged lipids that displace
the axial Met-80, allowing access of H2O2 or organic peroxides
(e.g. CL hydroperoxides) to activate its peroxidase activity,
which is typical for many members of the peroxidase family of
enzymes.
The present results demonstrate that 18O from 18O2was pre-
dominantly incorporated into the hydroxyl group of the -hy-
droxyaldehyde, whereas 18O from H218O was delivered to the
aldehyde carbon. This isotopic distribution indicates that the
reaction sequence is likely initiated from a stable resonance
form of vinyl ethers where an electron is transferred from
the -vinyl ether carbon (oxidation) to cyt c to form the allylic
radical intermediate, which can then readily add molecular
oxygen (Fig. 10). Next, the positive charge on the ether oxygen
is relieved by addition of water to form the hemiacetal, which at
neutral pH rearranges to form the lysolipid and the -hydroxy-
aldehyde. It is also likely that after addition ofmolecular oxygen
an epoxide can be formed, which then stereospecifically ring-
opens to form the hemiacetal with subsequent rearrangement
to the identified 2-acyl-lysolipid and -hydroxyaldehyde reac-
tion products (Fig. 10).
Typically, peroxidase activity results in incorporation of oxy-
gen from H2O2 into the oxidized substrate. However, we could
not observe any detectable incorporation of oxygen from
H218O2 into the-hydroxyaldehyde product. Thus, these stable
isotope studies identify an unusual reaction coordinate where
molecular oxygen is incorporated into the -vinyl ether carbon
whose hydrogen cannot be directly abstracted by a radical-
mediated mechanism. Instead, a stable resonance form is
utilized where an electron is extracted, effecting the oxida-
tion of the vinyl ether linkage by interactions with activated
cytochrome c. Moreover, it is unusual for peroxidases to
directly incorporate molecular oxygen without the use of a
radical intermediate (OH or RO), which would lead to sta-
ble isotope scrambling.
Previously, a mammalian enzyme capable of hydrolytic
cleavage of lysoplasmalogens through a nonoxidative mecha-
nism has been identified (51). However, despite intense efforts
to identify plasmalogen hydrolysis by this protein (Tmem86b,
HUGO 28448), the results demonstrated that this enzyme does
not possess plasmalogenase activity. Accordingly, Tmem86b
plays a role in lysoplasmalogen catabolism in liver (51) likely
with the obligatory participation of the lysoplasmalogen sn-2
hydroxy group through internal assistance that appears neces-
sary for catalysis as originally proposed 50 years ago (52). In
addition, leukocytemyeloperoxidase has been demonstrated to
indirectly hydrolyze the vinyl ether linkage of plasmalogens
through production of highly acidic HOCl orHOBr to generate
-haloaldehydes (53–57). Thus, the myeloperoxidase cleavage
of plasmalogens is acid-catalyzed and is not mechanistically
related to the oxidatively enabled hydrolytic cyt c–catalyzed
plasmalogenase reaction described herein.
The demonstration of plasmenylcholine and plasmenyletha-
nolamine in mitochondrial membranes suggests that cyto-
chrome c can regulate/modulatemultiplemitochondrial bioen-
ergetic and signaling functions through its plasmalogenase
activity. In addition, a substantial portion of myocardial mito-
chondria are in direct contact with the sarcoplasmic reticulum
(SR) by tethering to mitofusin1 (58). Because the SR is highly
enriched in plasmalogen molecular species (4) and tethered to
mitochondria, the activation of cyt c plasmalogenase activity
released from themitochondrial intermembrane compartment
in the immediate vicinity of the SR is anticipated to result in
plasmalogen cleavage and alterations in SR calcium homeosta-
sis. Furthermore, the existence of subsarcolemmal mitochon-
dria in myocardium is well known (59). Accordingly, we
propose that subsarcolemmal mitochondria can release
cytochrome c in close spatial juxtaposition to the sarcolemmal
membrane, which is highly enriched in plasmalogen molecular
species containing AA (3), identifying numerous potential sig-
naling functions. For example, lysolipids are known to precipi-
tate alterations in electrophysiologic function, including ven-
tricular tachyarrhythmias and sudden death (60), whereas
arachidonic acid and its metabolites modulate ion channel
kinetics (61, 62). Moreover, the highly reactive fatty acyl
-hydroxyaldehyde product is likely to covalently react with
multiple nucleophiles to form adducts, which could be det-
rimental to the function of critical enzymes (63, 64). Finally,
it is known that healthy cells can release small amounts of cyt
c frommitochondria (65, 66), which we speculate could serve
signaling functions between mitochondria and other intra-
cellular organelles/membranes.
Recently, we have demonstrated that cyclooxygenase (COX)-
2, but not COX-1, mediates the oxidation of 2-AA-LPC and
2-AA-LPE to generate specific eicosanoid lysolipids, which are
potentially important signaling molecules (67). The previously
unknown pathway identified in the current studies provides
an alternative route to the generation of 2-AA-lysolipids for
oxidation to biologically active signaling metabolites (Fig.
11). Alternatively, because plasmalogens are often highly
enriched in AA, the hydrolysis of 2-AA–containing lysolip-
ids by lysophospholipases can release arachidonic acid for
multiple downstream metabolic and signaling pathways
mediating proinflammatory and vasoactive effects among
others (68–71).
In regard to ischemia/reperfusion, it is well established that
themajority of cell death occurs in the center of the infarct zone
with varying degrees of cell survival in the border zones. Recent
studies have demonstrated that beneath a certain threshold
level of damage to mitochondria, cardiac myocytes are able to
remove these damaged mitochondria through mitophagy and
survive (72). However, when the level of damage exceeds that
which culling can adequately repair, cardiac myocyte death
ensues. Thus, the salvage of cardiac myocytes in the border
Plasmalogenase activity of cytochrome c














zone of an infarct is a primary goal of modern cardiology
research. The present study identifies both a likely mechanism
modulating mitochondrial communication and regulation of
cardiac metabolism and signaling in normal myocardium as
well as a potential therapeutic target for the salvage of damaged
cardiac myocytes in border zones or in failing hearts. The
potential implications of inhibiting this reaction to salvage
myocardium to decrease morbidity and mortality have pro-
found medical significance.
Previous studies have demonstrated a dramatic reduction
(60% decrease) of plasmalogen molecular species in brains of
patients with Alzheimer’s disease (AD) (e.g. see Ref. 73). Fur-
thermore, there have been numerous studies demonstrating
that mitochondrial dysfunction precedes the deposition of
amyloid and that mitochondrial oxidative stress or defective
axonal transport is the proximalmediator of cognitive dysfunc-
tion in AD (e.g. see Refs. 74 and 75). Moreover, previous studies
have identified the presence of -hydroxyaldehydes in patients
with AD, and the amount of -hydroxyaldehydes was highly cor-
related with the state of cognitive dysfunction (76). Accordingly,
we propose that cytochrome c–mediated degradation of plas-
malogens due to increased oxidative stress is a potential mecha-
nism responsible for the decrease in plasmalogens, membrane
dysfunction, altered intramembrane proteolysis, and resultant
cognitive abnormalities in patients with AD.
Collectively, the present study identifies conformationally
activated cytochrome c as the first plasmalogenase in biology.
Furthermore, cyt c initiates the cleavage of the vinyl ether bond
in plasmalogens by a previously undescribed oxidatively
enabled hydrolytic mechanism, generating a hemiacetal that
spontaneously rearranges to produce 2-acyl-lysolipids and
-hydroxyaldehydes. This process has the catalytic potential to
facilitate regulation of mitochondrial bioenergetics and signal-
ing as well as communication with distal membrane compart-




Equine cytochrome c (catalog number C7752) purified
utilizing acetic acid according to the method of Hagihara
et al. (77) and catalase (catalog number C40) from bovine liver
(used without further purification) were obtained from
Sigma-Aldrich. Recombinant bovine endothelial nitric-oxide
synthase (catalog number 60880) was purchased from Cay-
man Chemical. 1-O-1-(Z)-Octadecenyl-2-arachidonoyl-
sn-glycero-3-phosphocholine (catalog number 852469C),
1-O-1-(Z)-octadecenyl-2-arachidonoyl-sn-glycero-3-phospho-
ethanolamine (catalog number 852804C), 1-palmitoyl-2-
arachidonoyl-sn-glycero-3-phosphocholine (catalog number
850459C), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(catalog number 850457C), bovine heart cardiolipin (95%
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Figure 11. Lipid signaling pathways mediated by the plasmalogenase activity of cytochrome c. During oxidative stress, cytochrome c bound to
negatively charged phospholipids (e.g. oxidized cardiolipin (CLox)) undergoes a conformational change resulting in activation of its plasmalogenase
activity and targeting of plasmalogens within mitochondria. Alternatively, outer membrane permeabilization of mitochondria during oxidative stress
results in release of cytochrome c into the cytosol, leading to its association with negatively charged phospholipids in the mitochondrial outer
membrane (and associated membranes) or in other cellular membrane compartments (e.g. phosphatidylinositol phosphates (PIPx) in the plasma membrane). The
resultant 2-arachidonoyl-lysolipid and-hydroxyaldehyde products of cyt cplasmalogenase activity serve as signalingmolecules generated fromplasmalogen-rich
membranes. Furthermore, 2-arachidonoyl-lysolipids can either be esterified by acyl-CoA acyltransferases to diacyl phospholipids, metabolized by oxidases/oxyge-
nases (e.g.COXs, lipoxygenases (LOX), or cytochromesP450 (P450)) to yield novel natural products or alternatively undergohydrolysis (e.g.by lysophospholipases) to
generate signaling eicosanoids. ROS, reactive oxygen species; pPC, plasmenylcholine; pPE, plasmenylethanolamine.
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5-bisphosphate) (catalog number 850165P), 1-stearoyl-2-arachi-
donoyl-sn-glycero-3-phospho-(1-myo-inositol-3,4,5-tri-
sphosphate) (catalog number 850166P), 1,2-dimyristoleoyl-
sn-glycero-3-phosphocholine (14:1 PC) (catalog number
850346P), 1-heptadecanoyl-2-hydroxy-sn-glycero-3-phospho-
choline (17:0 LPC) (catalog number 855676P), 1,2-dipalmito-
leoyl-sn-glycero-3-phosphoethanolamine (16:1 PE) (catalog
number 850706P), 1-myristoyl-2-hydroxy-sn-glycero-3-phos-
phoethanolamine (14:0 LPE) (catalog number 856735P), and
hexadecanal-d9 (catalog number 857460 M) were purchased
from Avanti Polar Lipids. Most other reagents were obtained
from either Sigma-Aldrich or Fisher Scientific.
Preparation and purification of lipids
1-O-1-(Z)-Octadecenyl-2-arachidonoyl-sn-glycero-3-phos-
phoethanolaminewas purified prior to use utilizing anAscentis
C8HPLC column (250 4.6mm, 5m) using a linear gradient
of solvent A (57%methanol, 23% acetonitrile, 20% 10mM aque-
ous choline chloride) to solvent B (57%methanol, 43% acetoni-
trile) over 30 min. 2-AA-LPC and 2-AA-LPE were prepared by
acid hydrolysis of 1-O-1-(Z)-octadecenyl-2-arachidonoyl-sn-
glycero-3-phosphocholine and 1-O-1-(Z)-octadecenyl-
2-arachidonoyl-sn-glycero-3-phosphoethanolamine, respec-
tively, inmethanol, 1 N sulfuric acid (95:5) at 70 °C (30min) and
subsequent HPLC purification (78, 79).
Chromatographic purification of cytochrome c
Equine cytochrome cwas purchased from Sigma and further
purified by FPLC utilizing a Mono S column equilibrated with
20mMHEPES, pH7.4, containing 0.1mMDTPA. Briefly, 0.5mg
of solid equine cytochrome c was dissolved in 1 ml of 20 mM
HEPES, pH 7.4, containing 0.1 mM DTPA and applied to a
Mono S column equilibrated with the same buffer. Bound cyto-
chrome c was eluted from the Mono S FPLC column using a
linear gradient of NaCl (0–500 mM) over 25 column volumes.
Fractions (0.5 ml) were collected and assayed for plasmaloge-
nase activity using plasmenylcholine/CL SUVs in the presence
of hydrogen peroxide as described below. Larger scale purifica-
tions of cytochrome c (50 mg) were performed utilizing an SP
Sepharose column (1.5  15 cm) equilibrated with 20 mM
HEPES, pH 7.4, containing 0.1mMDTPA. Bound cytochrome c
was eluted with a linear NaCl gradient (500 mM final concen-
tration) over 12 column volumes (360ml). Eluted cytochrome c
was concentrated using Amicon centrifugal filter cartridges
(3000 molecular weight cutoff). The concentration of cyto-
chrome c was determined by the difference in absorbance
between fully oxidized cytochrome c and reduced cytochrome c
utilizing sodium dithionite (550 
 21.1 mM1 cm1) (80).
Absorbance determinations were made using a PerkinElmer
Life Sciences LAMBDA 25 UV/visible double beam spectro-
photometer with UVWinLab software.
Assay of plasmalogenase activity
For most reactions, 200 l of purified cytochrome c (10 M)
in 10 mM potassium phosphate, pH 7.0, containing 0.25 mM
DTPAwas incubatedwith small unilamellar vesicles of plasme-
nyl-SAPC (250 M) or plasmenyl-SAPE (125 M)/POPC (125
M) containing 10 mol % bovine heart cardiolipin (predomi-
nantly tetra-18:2 CL) with the indicated concentrations of
hydrogen peroxide for 10 min at 37 °C. The concentration of
hydrogen peroxide was measured using an extinction coeffi-
cient, 240, of 43.6 M1 cm1. For some reactions, cardiolipin
preoxidized by cytochrome c andH2O2 or phosphatidylinositol
phosphates (PI(4,5)P2 and PI(3,4,5)P3) were substituted for
nonoxidized cardiolipin. Reactions were terminated by addi-
tion of 1 ml of methanol, the samples were placed on ice, and 1
ml of chloroform was added. Next, appropriate internal stan-
dards (5 nmol of 17:0 LPC and 50 nmol of 14:1 PC for reactions
with plasmenylcholine and 5 nmol of 14:0 LPE and 50 nmol of
16:1 PE for reactionswith plasmenylethanolamine)were added.
Phase separation was induced by addition of 900 l of 25 mM
NaCl followed by vigorous vortexing and centrifugation to
effect phase partitioning. The water-methanol layer was re-ex-
tracted with chloroform and combined with the original chlo-
roform layer from the first extraction, and samples were dried
under a nitrogen stream.
Mass spectrometric identification and quantitation of
2-acyl-lysophospholipids
Mass spectrometric analysis was performed using a TSQ
Quantum Ultra mass spectrometer (Thermo Fisher Scientific,
San Jose, CA) equipped with an automated nanospray appara-
tus (Nanomate HD, Advion BioSciences, Ithaca, NY) for direct
infusionMS as described previously (81). The capillary temper-
ature of the mass spectrometer was set at 150 °C. The spray
voltage and gas pressure of theNanomatewere set at 1.3 kV and
1.1 p.s.i., respectively. Mass spectrometric analyses including
full-massMS1 spectra and tandemmass spectrometric analyses
were all performed in the positive-ion mode. Identification of
2-AA-LPC and 2-AA-LPE was performed by ESI-MS and/or
ESI-MS/MS mass spectrometric analyses of the sodiated
molecular ion atm/z 566 for 2-AA-LPC, the protonatedmolec-
ular ion atm/z 502 for 2-AA-LPE, or the sodiatedmolecular ion
atm/z 524 for 2-AA-LPE. The regiospecificity of AA-LPC and
AA-LPE was determined by the ratio of product ions as
described previously (46, 71). The sodiated 2-AA-LPC and
2-AA-LPE were also analyzed using a hybrid mass spectrome-
ter (LTQ-Orbitrap, Thermo Fisher Scientific) by direct infu-
sion in the positive-ion mode with sheath, auxiliary, and sweep
gas flows of 4, 1, and 0 arbitrary units, respectively. The capillary
temperature was set at 275 °C, the electrospray voltage was 4.0
kV, and tube lens were set to 100 V. The instrument was cali-
brated as instructed by the manufacturer prior to use. The iso-
lation width was set to 	1 thomson, normalized collision
energy was set at 30 eV for 2-AA-LPC and 22 eV for 2-AA-LPE,
and resolution was 30,000 at m/z 400. Instrument control and
data acquisition were performed using Thermo Xcalibur ver-
sion 2.1 software.
Derivatization andmass spectrometric identification of
-hydroxy fatty aldehydes
Reaction products from incubations of plasmenyl-SAPC
SUVs containing 10 mol % bovine heart CL in the presence or
absence of cyt c and H2O2 were extracted into an equal volume
of cyclohexane/diethyl ether (4:1). -Hydroxy fatty aldehydes
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were derivatized with DMG in a new tube by a modified proce-
dure (48) in the presence of hexadecanol (1 nmol) and analyzed
in the positive-ion mode. Briefly, to the dried cyclohexane/di-
ethyl ether extract, 5 l of a mixture of N,N-dimethylglycine
HCl (1 M) and DMAP (1 M) were added in anhydrous chloro-
form followed by addition of 10 l ofN-(3-dimethylaminopro-
pyl)-N-ethylcarbodiimide hydrochloride (0.25 M) in anhy-
drous chloroform, 200l of anhydrous chloroform, and 100mg
of 4-Å molecular sieve followed by vortexing and incubation at
45 °C for 60 min. Reactions were stopped by drying the solvent
under an N2 stream followed by resuspension in 200 l of iso-
propyl alcohol and analysis by LC-MS/MS as described below.
-Hydroxyaldehydes were also derivatized with BOA in the
presence of 1 ml of 0.1 M borax buffer, pH 9.4, containing 1
nmol of fatty aldehyde internal standard (hexadecanal-d9) as
described previously (47). Briefly, 2 mol of BOAwas added to
each reaction in borax buffer and incubated for 3 h at room
temperature. An equal volume of cyclohexane/diethyl ether
(4:1, v/v) was then added with vortexing and centrifuged
to separate organic and aqueous layers. The upper organic
layer was transferred to a new tube, 1ml of cyclohexane/diethyl
ether was added to the remaining aqueous phase, and the mix-
ture was vortexed and subsequently centrifuged to separate the
layers. The organic phases were combined and dried under a
nitrogen stream prior to mass spectral analysis.
The BOA- and DMG-derivatized -hydroxyaldehydes were
analyzed by LC-MS/MS using a Surveyor HPLC system and an
LTQ-Orbitrap mass spectrometer. The BOA- or DMG-deriva-
tized -hydroxyaldehydes were separated with a C18 reverse-
phase column (Kinetics EVO C18, 5 m, 150  2.1 mm) at
22 °Cwith a flow rate of 200l/min. A linear gradient of solvent
A (water with 10mM ammonium acetate, pH 4.3) and solvent B
(isopropyl alcohol) was used as follows: 0 min, 25% B; 5 min,
25%B; 20min, 100%B; 25min, 100%B; 25.1min, 25%B; 30min,
25% B. The sample injection volume was 10 l, and the
autosampler tray temperature was set at 4 °C. The spray voltage
in the ESI source was 4.1 kV. The sheath gas flow rate was 40.
The capillary temperature was 270 °C. The BOA- and DMG-
derivatized -hydroxyaldehydes were also analyzed by tandem
MS. The collision energy used was 30 eV (collision-induced
dissociation) for the BOA-derivatized sample and 35 eV (high-
energy collision dissociation) for the DMG-derivatized sample
with an isolation width of	1.5 thomsons.
Measurement of incorporation of 18O from 18O2 and H2
18O
into plasmalogenase reaction products
Plasmenyl-SAPC vesicles containing 10 mol % cardiolipin in
10mMpotassiumphosphate buffer, pH 7.0, containing 0.25mM
DTPA was 1) purged with 18O2 (97% 18O atom enrichment) in
a sealed 1-ml vial with a septum, 2) incubated with H218O (97%
18O atom enrichment), or 3) incubated with H218O2 (500 M
final concentration, 90% 18O atom enrichment). Concentrated
cytochrome c (1 mM) was then injected into the vial to 10 M
final concentration and vortexed.After incubation for 30min at
37 °C, the reaction was terminated by addition of 0.8 ml of cyc-
lohexane/diethyl ether (4:1) and vortexed. The upper organic
layer was removed, and the remaining aqueous layer was re-ex-
tractedwith 0.8ml of cyclohexane/diethyl ether (4:1). The com-
bined organic layers were then dried under a nitrogen stream
and subjected to derivatization and LC-MS/MS analysis as
described above.
Isolation of rabbit heart mitochondria, induction ofmPTP
opening, and release of cytochrome c
Male NewZealand rabbits were sedated with ketamine/xyla-
zine (35/5 mg/kg) prior to euthanasia with pentobarbital (150
mg/kg) and removal of the heart under a protocol approved by
the Washington University Animal Studies committee. After
thorough washing with PBS to remove excess blood, the heart
was finely diced with a razor blade prior to homogenization
using a Teflon homogenizer (150 rpm  10 passes) in mito-
chondrial isolation buffer (MIB) (10 mM HEPES, pH 7.4, con-
taining 0.21Mmannitol and 0.07M sucrose) containing 5mg/ml
fatty acid–free BSA. Following pelleting of myofibrils/nuclei/
cell debris by low speed centrifugation (1000  g for 7 min),
mitochondria were isolated from the resultant supernatant by
differential centrifugation at 10,000 g for 10 min. Mitochon-
driawerewashed three timeswithMIBwithout BSAbefore use.
Release of cyt c was induced by incubation of mitochondria in
MIB containing 75mMKCl and 75MCaHPO4 for 35 °C for 30
min. Swollen mitochondria were then pelleted by centrifuga-
tion at 10,000 g for 10min to obtain the supernatant fraction.
Proteins in the resultant supernatant and remainingmitochon-
dria (pelleted by centrifugation) were resolved by SDS-PAGE
(14% gel), transferred to PVDF membranes, and probed for
cytochrome c content by ECLWestern blot analysis utilizing a
monoclonal cyt c antibody and anti-mouse IgG-HRP conjugate
as described previously (83). The supernatant was analyzed for
plasmalogenase activity using CL oxidized by cyt c in the
absence or presence of a mAb (1 g) directed against cyt c as
described above.
Collection of human heart tissue and isolation of
mitochondria
Human heart tissue was obtained from Mid-America
Transplant (St. Louis, MO) and the Washington University
Translational Cardiovascular Tissue Core. Tissue from the
left ventricle and left ventricular apex of nonfailing human
hearts was obtained from organ donors having a heart
deemed unsuitable for transplantation due to donor age, epi-
cardial (nonocclusive) coronary vascular disease, or high risk
behavioral profile. All tissue was trimmed of excess fat,
washed in cold PBS, and then placed in ice-cold MIB prior to
isolation of mitochondria by differential centrifugation as
described previously (84).
Determination of plasmenyl-PC and plasmenyl-PE content of
human heart mitochondrial phospholipids by shotgun
lipidomics
Isolated human heart mitochondria were extracted into
chloroform using a Bligh-Dyer extraction method in the pres-
ence of internal standards (14:1 PC and 16:1 PE) as described
previously (85). Phosphatidylethanolamine phospholipidswere
derivatized with fluorenylmethoxycarbonyl (Fmoc) chloride as
described previously (86). Acid hydrolysis of plasmalogens was
performed as described above, cleaving only vinyl ether lipids
Plasmalogenase activity of cytochrome c














without affecting either diacyl or alkyl ether phospholipids. The
resultant lipid extracts were analyzed utilizing a TSQQuantum
Ultra Plus triple-quadrupole mass spectrometer as described
above.
Binding of cyt c to LUVs
LUVs were prepared by extrusion of 1-O-1-(Z)-octadece-
nyl-2-arachidonoyl-sn-glycero-3-phosphocholine (1.25 mM)
with or without nonoxidized CL (10 mol %) or previously oxi-
dized CL (10 mol %) in 10 mM potassium phosphate buffer, pH
7.0, containing 0.25 mM DTPA and 48 mM sucrose through a
0.8-m filter. LUVs (0.2 ml) were diluted 1:5 in 10 mM potas-
sium phosphate, pH 7.0, containing 0.25 mMDTPA and 25 mM
KCl prior to addition of purified cyt c (2.5 M final concentra-
tion). Following incubation for 5 min at room temperature, the
samples were then centrifuged at 100,000  g at 15 °C for 1 h.
The supernatants were removed, and the pelleted LUVs were
resuspended in 0.5ml of buffer prior to analysis of cyt c content
by SDS-PAGE and immunoblot analysis as described above.
Oxidation of cardiolipin by cytochrome c and hydrogen
peroxide
Bovine heart cardiolipin was oxidized by cyt c as described
previously (87) with minor modifications. Briefly, CL SUVs
(250 M) in 10 mM potassium phosphate buffer, pH 7.0, con-
taining 0.25mMDTPAwere incubated with cyt c and hydrogen
peroxide at 37 °C for 40min. Cytochrome c (10 nmol) andH2O2
(50 nmol) were added at 10-min intervals to achieve 50 and 250
M final concentrations, respectively, at the end of the incuba-
tion. Following addition of KCl to 100 mM, oxidized CL was
extracted into chloroform following the Folch extraction
method (82).
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